SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001214659-21-007963
Filing Date
2021-07-29
Accepted
2021-07-29 17:19:44
Documents
68
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 d72421010k.htm 10-K 1153691
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 2473
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 9135
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 9010
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6831
6 GRAPHIC p4_chart.jpg GRAPHIC 133258
7 GRAPHIC p11_chart.jpg GRAPHIC 330394
8 GRAPHIC p19_chart.jpg GRAPHIC 143554
  Complete submission text file 0001214659-21-007963.txt   5584902

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE alzn-20210430.xml EX-101.INS 752603
10 XBRL SCHEMA FILE alzn-20210430.xsd EX-101.SCH 51775
11 XBRL CALCULATION FILE alzn-20210430_cal.xml EX-101.CAL 45427
12 XBRL DEFINITION FILE alzn-20210430_def.xml EX-101.DEF 217722
13 XBRL LABEL FILE alzn-20210430_lab.xml EX-101.LAB 365234
14 XBRL PRESENTATION FILE alzn-20210430_pre.xml EX-101.PRE 301814
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-40483 | Film No.: 211128656
SIC: 2834 Pharmaceutical Preparations